Bleakley Financial Group’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-1,020
Closed -$259K – 720
2024
Q4
$259K Sell
1,020
-821
-45% -$220K 0.01% 850
2024
Q3
$583K Buy
1,841
+237
+15% +$84.4K 0.02% 553
2024
Q2
$599K Sell
1,604
-10,725
-87% -$3.62M 0.02% 548
2024
Q1
$4.27M Sell
12,329
-5,193
-30% -$1.97M 0.12% 160
2023
Q4
$8.02M Sell
17,522
-4,409
-20% -$2.17M 0.25% 75
2023
Q3
$10.7M Buy
21,931
+2,293
+12% +$1.08M 0.38% 52
2023
Q2
$8.78M Buy
19,638
+211
+1% +$106K 0.27% 68
2023
Q1
$9.43M Buy
19,427
+5,014
+35% +$2.48M 0.31% 63
2022
Q4
$7.38M Buy
+14,413
New +$7.58M 0.26% 78

Other funds holding HUM

Bleakley Financial Group's HUM Position: Q1 2025 in Review

Bleakley Financial Group sold out of Humana (HUM) in Q1 2025, closing a stake of 1,020 shares — an estimated $259K sold.

Bleakley Financial Group first reported a position in HUM in Q4 2022 and held it in 9 quarters. The position peaked at $10.7M in Q3 2023. 903 funds tracked by Wall St. Rank hold HUM as of Q1 2025.

  • Bleakley Financial Group reported no remaining Humana position as of Q1 2025 after selling out during the quarter.
  • Bleakley Financial Group sold 1,020 Humana shares in Q1 2025, an estimated $259K.
  • Bleakley Financial Group first reported a position in Humana in Q4 2022 and held it in 9 quarters.
  • Bleakley Financial Group's Humana position peaked at $10.7M in Q3 2023.
  • 903 funds tracked by Wall St. Rank held Humana as of Q1 2025.

Based on Bleakley Financial Group's 13F filing for Q1 2025, filed 1 May 2025.